Skip to main content

Penumbra Inc 8-K, filed Oct 29, 2026

Penumbra Inc (PEN)

8-K 2026-10-29 For: 2026-10-29
View Original
Added on October 29, 2026

About this 8-K

Penumbra Inc filed this 8-K on October 29, 2026.

Penumbra Inc reported third-quarter 2026 revenue of $410.1 million, up 15.6%, global thrombectomy revenue of $279.2 million, up 18.1%, and net income of $42.3 million; pending acquisition by Boston Scientific Corporation led it to withhold full year 2026 guidance. AI summary

Items reported

  • Item 2.02: Financial results
  • Item 9.01: Financial statements and exhibits